RMD
ResMed Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
-2/100
Last price
220.69
▼ 2.17 (0.97%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
223.90
Prev close
222.86
Day high
225.23
Day low
219.96
Volume
972.57K
Market cap
$31.04B
P/E (TTM)
21.36
52W range
180.27 – 284.87
Day trading desk
Gap from prior close
+0.47%
Prior close 222.86
VWAP
221.26
-0.26% from price
Relative volume
1.02×
Normal
Session range
2.40%
219.96 – 225.23
Position in range
14%
Near session low
ATR (14D)
4.57
2.07% of price
Prior day high
223.72
PDH
Prior day low
218.44
PDL
Bid / ask spread
—
Quote not published
Session volume
1.38M
Avg 1.35M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.96%
-2.9%
1M
-3.35%
-4.5%
3M
+7.21%
+2.7%
6M
-2.37%
-20.6%
YTD
-8.38%
-22.6%
1Y
-20.78%
-37.2%
3Y
+49.25%
-33.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on RMD open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+7.53K
Net buying
Buy transactions
7
40.49K shares
Sell transactions
6
32.95K shares
Net transactions
+13
Buys less sells
Sell : buy shares
0.8 : 1
Mixed
Insider-held shares
728.47K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 8, 26 | FARRELL MICHAEL J Chief Executive Officer |
SELL | 4.99K | $1.11M | Direct |
| Sep 8, 26 | FARRELL MICHAEL J Chief Executive Officer |
CONVERSION | 4.99K | $730.38K | Direct |
| Aug 14, 26 | BLOOMER AARON Chief Financial Officer |
STOCK | 9.07K | $0 | Direct |
| Aug 14, 26 | LEONG JUSTIN Officer |
STOCK | 6.46K | $0 | Direct |
| Aug 7, 26 | FARRELL MICHAEL J Chief Executive Officer |
SELL | 4.99K | $1.03M | Direct |
| Aug 7, 26 | FARRELL MICHAEL J Chief Executive Officer |
CONVERSION | 4.99K | $730.38K | Direct |
| Aug 5, 26 | FARRELL PETER CRAIG Director |
SELL | 8.00K | $1.80M | Direct |
| Jun 8, 26 | FARRELL MICHAEL J Chief Executive Officer |
SELL | 4.99K | $968.06K | Direct |
| Jun 8, 26 | FARRELL MICHAEL J Chief Executive Officer |
CONVERSION | 4.99K | $730.38K | Direct |
| May 7, 26 | FARRELL MICHAEL J Chief Executive Officer |
SELL | 4.99K | $1.04M | Direct |
| May 7, 26 | FARRELL MICHAEL J Chief Executive Officer |
CONVERSION | 4.99K | $730.38K | Direct |
| Apr 7, 26 | FARRELL MICHAEL J Chief Executive Officer |
SELL | 4.99K | $1.13M | Direct |
| Apr 7, 26 | FARRELL MICHAEL J Chief Executive Officer |
CONVERSION | 4.99K | $730.38K | Direct |
| Apr 1, 26 | FARRELL PETER CRAIG Director |
SELL | 2.00K | $450.00K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BURT CAROL J |
Director | 18.82K | Stock Award(Grant) |
FARRELL MICHAEL J |
Chief Executive Officer | 468.35K | Sale |
FARRELL MICHAEL J. |
Chief Executive Officer | 469.88K | Sale |
FARRELL PETER CRAIG |
Director | 52.77K | Sale |
GHOSHAL KAUSHIK |
Officer | 19.35K | Sale |
GILL HARJIT |
Director | 10.94K | Stock Award(Grant) |
LEONG JUSTIN |
Officer | 35.49K | Stock Award(Grant) |
SANDERCOCK BRETT |
Chief Financial Officer | 83.50K | Sale |
SULPIZIO RICHARD |
Director | 17.80K | Stock Award(Grant) |
TAYLOR RONALD R |
Director | 24.77K | Stock Award(Grant) |
Fundamentals
Market cap$31.04B
Enterprise value$31.19B
Revenue (TTM)$5.65B
Gross profit$3.48B
EBITDA$2.10B
Net income$1.52B
EPS (TTM)$10.33
Free cash flow$939.25M
Total cash$1.47B
Total debt$825.92M
Book value / share$45.66
Shares outstanding140.64M
Float143.32M
Short % of float11.35%
Dividend yield1.18%
Beta (5Y)0.75
Valuation & profitability ratios
Trailing P/E21.36
Forward P/E16.68
PEG ratio1.29
Price / sales—
Price / book4.83
EV / revenue5.52
EV / EBITDA14.88
Gross margin61.62%
Operating margin30.86%
Profit margin26.95%
Return on equity24.27%
Return on assets14.00%
Debt / equity12.54
Current ratio3.10
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $5.65B | $5.15B | $4.69B | $4.22B | — | +9.9% |
| Operating revenue | $5.65B | $5.15B | $4.69B | $4.22B | — | +9.9% |
| Cost of revenue | $2.20B | $2.09B | $2.03B | $1.87B | — | +5.3% |
| Gross profit | $3.45B | $3.05B | $2.66B | $2.36B | — | +13.0% |
| Research & development | $378.29M | $331.28M | $307.52M | $287.64M | — | +14.2% |
| Selling, general & admin | $1.12B | $993.05M | $917.14M | $874.00M | — | +12.7% |
| Total operating expense | $1.54B | $1.37B | $1.27B | $1.20B | — | +12.7% |
| Operating income | $1.91B | $1.69B | $1.38B | $1.15B | — | +13.2% |
| Net interest income | $49.91M | $4.11M | -$45.71M | -$47.38M | — | +1,113.3% |
| Pre-tax income | $1.92B | $1.68B | $1.26B | $1.10B | — | +14.4% |
| Tax provision | $396.12M | $276.84M | $243.85M | $204.11M | — | +43.1% |
| Net income | $1.52B | $1.40B | $1.02B | $897.56M | — | +8.8% |
| Net income to common | $1.52B | $1.40B | $1.02B | $897.56M | — | +8.8% |
| Basic EPS | — | — | 6.94 | 6.12 | 5.34 | — |
| Diluted EPS | — | — | 6.92 | 6.09 | 5.30 | — |
| EBIT | $1.91B | $1.69B | $1.38B | $1.15B | — | +13.2% |
| EBITDA | $2.15B | $1.92B | $1.60B | $1.35B | — | +12.0% |
| Basic shares | — | — | 147.02M | 146.76M | 146.07M | — |
| Diluted shares | — | — | 147.55M | 147.46M | 147.04M | — |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.47B | $1.21B | $238.36M | $227.89M | +21.5% |
| Cash & short-term investments | $1.47B | $1.21B | $238.36M | $227.89M | +21.5% |
| Accounts receivable | $1.04B | $939.49M | $837.27M | $704.91M | +10.3% |
| Inventory | $945.80M | $927.71M | $822.25M | $998.01M | +2.0% |
| Total current assets | $4.32B | $3.51B | $2.36B | $2.37B | +23.4% |
| Property, plant & equipment | $735.00M | $718.29M | $699.15M | $665.81M | +2.3% |
| Goodwill & intangibles | $3.36B | $3.51B | $3.33B | $3.32B | -4.2% |
| Total assets | $8.97B | $8.17B | $6.87B | $6.75B | +9.7% |
| Total current liabilities | $1.40B | $1.02B | $910.65M | $758.53M | +36.9% |
| Current debt | $259.95M | $9.90M | $9.90M | $9.90M | +2,525.8% |
| Long-term debt | $399.42M | $658.39M | $697.31M | $1.43B | -39.3% |
| Total debt | $825.92M | $851.81M | $873.93M | $1.58B | -3.0% |
| Total liabilities | $2.38B | $2.21B | $2.01B | $2.62B | +7.9% |
| Retained earnings | $7.26B | $6.08B | $4.99B | $4.25B | +19.3% |
| Shareholder equity | $6.59B | $5.97B | $4.86B | $4.13B | +10.3% |
| Working capital | $2.93B | $2.49B | $1.45B | $1.61B | +17.8% |
| Net tangible assets | $3.22B | $2.46B | $1.54B | $807.26M | +31.2% |
| Shares issued | 144.24M | 190.31M | 189.57M | 188.90M | -24.2% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $1.52B | $1.40B | $1.02B | $897.56M | +8.8% |
| Depreciation & amortisation | $244.15M | $235.81M | $216.21M | $197.56M | +3.5% |
| Stock-based compensation | $104.35M | $91.66M | $80.18M | $71.14M | +13.8% |
| Change in working capital | -$74.24M | $16.74M | $44.78M | -$462.13M | -543.6% |
| Operating cash flow | $1.81B | $1.75B | $1.40B | $693.30M | +3.1% |
| Capital expenditure | -$177.17M | -$100.64M | -$114.86M | -$134.00M | -76.0% |
| Investing cash flow | -$545.20M | -$200.04M | -$269.78M | -$1.16B | -172.5% |
| Share buybacks | -$700.04M | -$300.02M | -$150.01M | $0 | -133.3% |
| Dividends paid | -$349.66M | -$310.88M | -$282.32M | -$258.28M | -12.5% |
| Financing cash flow | -$1.01B | -$606.25M | -$1.12B | $422.87M | -66.1% |
| Free cash flow | $1.63B | $1.65B | $1.29B | $559.30M | -1.4% |
| End cash position | $1.47B | $1.21B | $238.36M | $227.89M | +21.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.46B | $1.43B | $1.42B | $1.34B | $1.35B | +2.3% |
| Operating revenue | $1.46B | $1.43B | $1.42B | $1.34B | $1.35B | +2.3% |
| Cost of revenue | $602.43M | $540.43M | $544.08M | $514.76M | $527.92M | +11.5% |
| Gross profit | $861.22M | $890.98M | $878.72M | $820.82M | $820.07M | -3.3% |
| Research & development | $105.72M | $94.27M | $90.97M | $87.32M | $86.44M | +12.2% |
| Selling, general & admin | $296.28M | $285.65M | $278.40M | $259.19M | $265.13M | +3.7% |
| Total operating expense | $412.51M | $391.17M | $381.13M | $358.47M | $363.50M | +5.5% |
| Operating income | $448.71M | $499.81M | $497.60M | $462.35M | $456.57M | -10.2% |
| Net interest income | $20.89M | $12.29M | $7.95M | $8.79M | $5.76M | +70.0% |
| Pre-tax income | $474.16M | $502.31M | $496.15M | $446.79M | $458.05M | -5.6% |
| Tax provision | $90.73M | $103.58M | $103.56M | $98.26M | $78.35M | -12.4% |
| Net income | $383.43M | $398.73M | $392.59M | $348.54M | $379.70M | -3.8% |
| Net income to common | $383.43M | $398.73M | $392.59M | $348.54M | $379.70M | -3.8% |
| Basic EPS | 2.65 | 2.74 | 2.69 | 2.38 | 2.59 | -3.3% |
| Diluted EPS | 2.64 | 2.74 | 2.68 | 2.37 | 2.58 | -3.6% |
| EBIT | $448.71M | $499.81M | $497.60M | $462.35M | $456.57M | -10.2% |
| EBITDA | $503.83M | $568.84M | $559.92M | $520.02M | $530.86M | -11.4% |
| Basic shares | 144.71M | 145.34M | 145.84M | 146.18M | 146.47M | -0.4% |
| Diluted shares | 144.98M | 145.72M | 146.37M | 146.90M | 147.04M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.47B | $1.66B | $1.42B | $1.38B | $1.21B | -11.5% |
| Cash & short-term investments | $1.47B | $1.66B | $1.42B | $1.38B | $1.21B | -11.5% |
| Accounts receivable | $1.04B | $998.84M | $985.63M | $907.27M | $939.49M | +3.7% |
| Inventory | $945.80M | $911.88M | $922.04M | $945.81M | $927.71M | +3.7% |
| Total current assets | $4.32B | $4.06B | $3.82B | $3.63B | $3.51B | +6.4% |
| Property, plant & equipment | $735.00M | $728.57M | $730.17M | $725.64M | $718.29M | +0.9% |
| Goodwill & intangibles | $3.36B | $3.47B | $3.47B | $3.49B | $3.51B | -3.1% |
| Total assets | $8.97B | $8.78B | $8.50B | $8.31B | $8.17B | +2.1% |
| Total current liabilities | $1.40B | $1.35B | $1.25B | $1.26B | $1.02B | +3.2% |
| Current debt | $259.95M | $259.93M | $259.91M | $259.90M | $9.90M | +0.0% |
| Long-term debt | $399.42M | $404.17M | $403.92M | $408.66M | $658.39M | -1.2% |
| Total debt | $825.92M | $843.17M | $847.72M | $846.35M | $851.81M | -2.0% |
| Total liabilities | $2.38B | $2.29B | $2.18B | $2.19B | $2.21B | +3.8% |
| Retained earnings | $7.26B | $6.96B | $6.65B | $6.34B | $6.08B | +4.3% |
| Shareholder equity | $6.59B | $6.49B | $6.32B | $6.12B | $5.97B | +1.4% |
| Working capital | $2.93B | $2.71B | $2.57B | $2.37B | $2.49B | +8.0% |
| Net tangible assets | $3.22B | $3.02B | $2.85B | $2.63B | $2.46B | +6.6% |
| Shares issued | 144.24M | 190.87M | 190.81M | 190.39M | 190.31M | -24.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $383.43M | $398.73M | $392.59M | $348.54M | $379.70M | -3.8% |
| Depreciation & amortisation | $55.12M | $69.03M | $62.33M | $57.67M | $74.29M | -20.2% |
| Stock-based compensation | $27.46M | $26.79M | $28.94M | $21.16M | $24.75M | +2.5% |
| Change in working capital | -$8.37M | $51.16M | -$142.29M | $25.25M | $58.76M | -116.4% |
| Operating cash flow | $454.63M | $554.13M | $339.75M | $457.32M | $538.77M | -18.0% |
| Capital expenditure | -$57.25M | -$39.59M | -$34.55M | -$45.78M | -$33.78M | -44.6% |
| Investing cash flow | -$383.65M | -$58.03M | -$50.94M | -$52.58M | -$133.71M | -561.1% |
| Share buybacks | -$200.00M | -$175.01M | -$175.01M | -$150.01M | -$100.01M | -14.3% |
| Dividends paid | -$87.09M | -$87.24M | -$87.58M | -$87.75M | -$77.59M | +0.2% |
| Financing cash flow | -$263.16M | -$255.24M | -$258.35M | -$230.27M | -$163.89M | -3.1% |
| Free cash flow | $397.38M | $514.54M | $305.19M | $411.54M | $504.99M | -22.8% |
| End cash position | $1.47B | $1.66B | $1.42B | $1.38B | $1.21B | -11.5% |
Options analytics
Put / call volume
0.35
Call-heavy session
Put / call open interest
0.61
Positioning, not flow
Max pain
230.00
+4.2% from spot
ATM implied vol
33.3%
Nearest strike to spot
Skew (10% OTM)
+9.4%
Puts bid over calls
Call volume
742
Contracts, this expiry
Put volume
257
Contracts, this expiry
Heaviest call OI
250.00
688 contracts
Heaviest put OI
230.00
281 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.89 | 2.95 | +2.0% |
| Mar 2026 | 2.80 | 2.86 | +2.2% |
| Dec 2025 | 2.72 | 2.81 | +3.2% |
| Sep 2025 | 2.50 | 2.55 | +2.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.67 | 13 | $1.39B | +4.1% |
| Next quarter | 3.03 | 13 | $1.45B | +2.0% |
| Current year | 12.09 | 20 | $5.81B | +2.7% |
| Next year | 13.23 | 20 | $6.17B | +6.3% |
Analyst targets & ownership
Mean target$250.22
High target$320.00
Low target$175.00
Implied upside13.38%
Analyst count17
ConsensusBUY
Strong buy / Buy2 / 7
Hold10
Sell / Strong sell1 / 0
Held by insiders0.51%
Held by institutions72.94%
Institutions holding1.34K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
221.58
-0.40% from price
SMA 20
222.66
-0.89% from price
SMA 50
224.17
-1.55% from price
SMA 100
211.43
+4.38% from price
SMA 200
225.46
-2.11% from price
EMA 12
222.10
-0.63% from price
EMA 26
223.03
-1.05% from price
EMA 50
221.23
-0.25% from price
RSI (14)
45.6
Neutral
MACD (12,26,9)
-0.93
Hist -0.46
ATR (14)
4.57
2.07% of price
Realised vol 30D
21.3%
Annualised
Bollinger upper
228.63
20, 2σ
Bollinger lower
216.70
20, 2σ
50 / 200 cross
Death
224.17 vs 225.46
Trend bias
Below 200
-2.11%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.40
Less volatile than market
Correlation to SPY
0.18
Largely independent
Realised vol 30D
21.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-35.5%
Peak to trough
Max drawdown 5Y
-49.9%
Peak to trough
ATR 14
4.57
2.07% of price
Beta (reported)
0.75
5Y monthly, from filing
Short interest
Shares short
14.20M
Prior 12.79M
Change vs prior
+11.0%
Shorts adding
% of float
11.35%
Elevated
% of shares out
9.85%
Against total outstanding
Days to cover
10.6
Crowded exit
Float
143.32M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 26 | RBC Capital | UPGRADE | Sector Perform | Outperform |
| Aug 31, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Aug 19, 26 | Rothschild & Co | INITIATED | — | Neutral |
| Aug 7, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Aug 7, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Aug 7, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 15, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 13, 26 | Citigroup | DOWNGRADE | Buy | Neutral |
| Jul 10, 26 | Jefferies | MAINTAINED | Hold | Hold |
| Jul 8, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 8, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate$2.64 / yr
Forward yield1.18%
5-year avg yield0.86%
Payout ratio23.01%
Ex-dividend dateAug 20, 2026
Next pay dateSep 24, 2026
Last split2:1
Split dateAug 31, 2010
SEC filings
Proxy Statements
DEF 14A · 2026-10-01
Corporate Changes & Voting Matters
8-K · 2026-09-01
Corporate Changes & Voting Matters
8-K · 2026-08-17
Periodic Financial Reports
10-K · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-07
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-26
Periodic Financial Reports
10-Q · 2026-05-01
Headlines
ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 1d ago
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
StockStory · 5d ago
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
GlobeNewswire · 5d ago
This Stock Could Be the Big Winner Out of Oura’s IPO
Barrons.com · 8d ago
Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
Trefis · 8d ago
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
MarketBeat · 15d ago
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
Insider Monkey · 18d ago
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
Barrons.com · 21d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.